logo
Quick Facts
Plus   Neg
Share
Email

Merck Acquires Biochrom

By RTTNews Staff Writer   ✉   | Published:

Biochrom AG (MKGAY.PK) announced that Merck & Co. Inc.(MRK) entered into a definitive agreement to acquire Biochrom AG. The acquisition is subject to customary closing conditions, including approval by the relevant antitrust authorities.

The transaction is expected to close in the fourth-quarter of 2012.

The Berlin location Biochrom AG is to be maintained. The activities of Biochrom be integrated into the Process Solutions business unit of Merck Millipore.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
J&J Distributing Recalls Multiple Food Products For Listeria Concerns
J&J Distributing has recalled various food products citing potential contamination with Listeria monocytogenes or Lm, an organism that can cause serious and sometimes fatal infections. According to the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS, around 33 pounds of ready-to-eat meat and poultry salads and wrap products have been called back.
FDA Authorizes Emergency Use Of Johnson & Johnson's Single-dose COVID-19 Vaccine
The U.S. Food and Drug Administration on Saturday authorized Johnson & Johnson's (JNJ) single-dose COVID-19 vaccine for emergency use. It is the first single-shot COVID-19 vaccine and the third COVID-19 vaccine for emergency use in the U.S. - the other two being Pfizer/BioNTech's BNT162b2 and Moderna's mRNA-1273.
FDA Says 'rapidly Works Toward' Emergency Use Approval Of J&J's Single-shot COVID-19 Vaccine
The U.S. Food and Drug Administration said that it will rapidly work toward finalization and issuance of an emergency use authorization of Johnson & Johnson's (JNJ) single-shot COVID-19 vaccine candidate.
Latest Updates on COVID-19
Read More
COVID-19: Drugs in Development
Follow RTT
Copyright © 2021 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap